More Keys to Define Moderate Aortic Stenosis

Amidst the current efforts to prove early intervention might have benefits in moderate aortic stenosis (AS), this trial comes along directing us back to basics. 

estenosis aórtica moderada

In patients with symptomatic aortic stenosis, peaking mortality will clearly justify intervention. But what is the case when there are no symptoms? According to this recent analysis published in JAMA, asymptomatic moderate aortic stenosis does not bring about higher mortality when compared against mild AS

Therefore, we will end up going back to the traditional approach based on symptoms (look closely and wait) when it comes to moderate AS. 

However, the new trend that resorts to prognostic factors to find patients that will benefit from an early intervention must continue

In this study, mortality observed in mild AS was no different from expected mortality in the general population. Patients with moderate AS did show higher mortality risk vs. the general population (though still far from that of severe AS patients). 

This slightly more elevated mortality in moderate AS patients was found in symptomatic patients. Why would moderate AS present with symptoms? The answer to this question is that stenosis might have never been properly assessed and that there might be patients requiring additional markers.


Read also: STOPDAPT-2 ACS: One-Month DAPT NOT Enough in acute patients.


At this point, we might be able to combine the traditional approach with the new trend: waiting for symptoms to show works for most patients; however, some patients (the number still unknown) will benefit from additional assessment and, perhaps, early intervention. 

The VALVENOR included 2703 ambulatory patients with AS. Stenosis degree was defined according to peak velocity in transthoracic ECG, resulting in 42.7% mild AS (2.5 to 2.9 m/sec velocity), 41.5% moderate AS (3 to 3.9 m/sec velocity) and 15.8% severe AS (≥4 m/sec peak velocity).

There were no differences in the rest of baseline characteristics.


Read also: The FDA Approves a Third Device in the TAVR Race.


During followup, 775 patients showed stenosis progress by ECG: 45.2% showed mild to moderate progress, 7.7% mild to severe and 47.1% moderate to severe.

634 of 775 patients who progressed were intervened. Non-intervention was decided upon patient refusal or death while waiting for the procedure. 

Our efforts should aim at finding patients with moderate AS who will progress faster than expected or will die of heart disease (cardiac failure or sudden death). 

Original Title: Association of mortality with aortic stenosis severity in outpatients: results from the VALVENOR study.

Reference: Coisne A et al. JAMA Cardiol. 2021 Sep 29. Online ahead of print. doi: 10.1001/jamacardio.2021.3718. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...